ClinConnect ClinConnect Logo
Search / Trial NCT02212470

Drug Eluting Balloon Angioplasty Versus Nitinol Stent Implantation in the Superficial Femoral Artery

Launched by INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA · Aug 7, 2014

Trial Information

Current as of June 06, 2025

Completed

Keywords

Artery Atherosclerosis Peripheral Arterial Plaque Pta Angioplasty Femoropopliteal Self Expandable Nitinol Stents

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients over 18 years with critical lower limb ischemia,
  • Ruhtherford 3 or higher,
  • with angiographic documentation of greater than 70% or occlusion in the superficial femoral artery,
  • with a maximum extension of 10 cm stenosis.
  • The popliteal artery and at least one leg artery must be patent.
  • Exclusion Criteria:
  • Pregnancy,
  • thrombophilia,
  • coagulation disorders,
  • presence of active or recent bleeding,
  • severe allergy to iodinated contrast,
  • renal or hepatic disease,
  • acute limb ischemia,
  • prior surgical bypass or angioplasty (with or without stent) on the target artery,
  • obstructive disease (stenosis\> 50%) of the aortoiliac segment ipsilateral to the target (if the aortoiliac is pre-treated, the patient may be included)

About Instituto Dante Pazzanese De Cardiologia

Instituto Dante Pazzanese de Cardiologia is a leading clinical research institution based in Brazil, dedicated to advancing cardiovascular medicine through innovative research and clinical trials. Renowned for its commitment to improving patient outcomes, the institute specializes in a wide array of cardiovascular conditions and interventions. With a multidisciplinary team of experts, state-of-the-art facilities, and a robust network of collaboration, Instituto Dante Pazzanese de Cardiologia plays a pivotal role in contributing to the scientific community and enhancing the understanding of heart diseases, ultimately striving to translate research findings into effective clinical practices.

Locations

Sao Paulo, , Brazil

Patients applied

0 patients applied

Trial Officials

BRUNO L ALMEIDA, MD

Principal Investigator

Instituto Dante Pazzanese de Cardiologia

FABIO H ROSSI, MD, PHD

Study Director

Instituto Dante Pazzanese de Cardiologia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials